The general objective of the conference is in line with the Objective of the 2nd Programme of Community action in the field of health (2008-13): to improve citizens’ health security, by pursuing Act...
The general objective of the conference is in line with the Objective of the 2nd Programme of Community action in the field of health (2008-13): to improve citizens’ health security, by pursuing Action: Protect citizens against health threats. The conference main goal is to underpin the corresponding priority in the 2008 annual Work Plan: Enhance capacity building (point 188.8.131.52) – and could aid in identifying future action and needs in this area.
Several EU Member States operate high containment laboratories (with emphasis on BSL4 or P4 laboratories) as part of their national biopreparedness strategy. These facilities provide essential diagnostic capacity in case of outbreaks (emerging infectious diseases or biological threats). Several other EU Member States are developing plans for high containment laboratories, or have them currently under construction. They are confronted with restrictive EU( not aware of any restrictions , the only legislation in place is the health at workplace directive) and national regulations, and international standards and guidelines that are not always consistent( or not coherent,). In addition, there are many national and EU projects and networks funded under current and previous Programmes, which focus mainly on biopreparedness, biosafety, biosecurity, capacity building and training, or exchange of reagents, protocols and good practice. Lastly, there are several relevant priority actions in the current Health Programme, which include development of Community reference laboratories and sharing facilities and equipment. EU Member States and organizations with new high containment laboratories will need to connect with ongoing initiatives and overall they need maximize synergy and cooperation across EU Member States.
Specific objectives of the conference:
a) To bring together a forum of experts in all fields pertinent to high containment facilities, and to create an opportunity for new high containment facilities to benefit from lessons-learned in the area of Biopreparedness and Research on high-risk biological agents;
b) To provide a stepping stone for bringing together European initiatives of high-level bio- containment laboratories and for stimulating future networking and capacity building.
At this level , there is clearly an overlap with the takss given to the ENP4 and no clear demonstration of added value